Follicle-stimulating hormone (FSH)-mediated changes in granulosa cell adhesion and morphology are essential for preovulatory follicle development, given the dramatic changes in follicle size and granulosa cell number that occur during this transition. Members of the Eph-ephrin family of cell-positioning and adhesion molecules, a family that consists of ephrin ligands and their Ephrin (Eph) receptors, regulate cell location, adhesion, and migration during embryonic development and tumor growth. However, very little is known about ephrin signaling during folliculogenesis. We have found that FSH increases the expression of several members of the Eph-ephrin family and that this signaling regulates granulosa cell morphology and adhesion. FSH induced increased mRNA levels of the ephrin ligand, ephrin-A5 (Efna5), and its receptors, Eph receptors A3, A5, and A8 (Epha3, Epha5, and Epha8, respectively), in granulosa cells. Immunofluorescence studies indicated that EFNA5 and EPHA5 are located in the membrane of granulosa cells of developing mouse follicles. Eph-ephrin signaling directly affected granulosa cell morphology and adhesion. Recombinant EFNA5 reduced cell spreading and increased cell rounding in mouse primary granulosa cells and in a rat granulosa cell line, whereas EPHA5 reduced granulosa cell adhesion in both model systems. Both FSH and forskolin also increased Efna5 and Epha5 mRNA levels in rat and human granulosa cell lines, indicating that FSH regulates these genes via the cAMP-dependent protein kinase A pathway and that this regulation is conserved across different species. The present study identifies Eph-ephrin signaling as a novel FSH-mediated pathway regulating granulosa cell morphology and adhesion.
INTRODUCTION
The successful formation of a preovulatory follicle in response to follicle-stimulating hormone (FSH) requires dramatic changes in the follicle, including an increase in follicle size and granulosa cell (GC) number, GC differentiation, and formation of an antrum. FSH also induces changes in GC morphology and adhesion that are essential for preovulatory follicle development both in vivo and in vitro [1] . Interestingly, changes in GC morphology and adhesion can also be induced by proteins of the extracellular matrix (ECM) during preovulatory follicle formation [1] . Alterations in GC morphology are largely attributed to modifications of the cytoskeleton resulting from signals from the ECM or adherens junctions, whereas GC adhesion and contact are primarily mediated by gap junctions, tight junctions, and adherens junctions [1] . However, few other mechanisms regulating GC morphology and contact have been identified. Recently, the Eph-ephrin family of molecules, a family that consists of ephrin ligands and their Ephrin (Eph) receptors, has been shown to regulate both cellular shape and adhesion during development, cancer, and the normal function of many different tissues [2, 3] . Although members of the Eph-ephrin family have been identified in the ovary, Eph-ephrin signaling and the role it may play during folliculogenesis have not been well-characterized.
Ephrin receptors comprise the largest known family of receptor tyrosine kinases (RTKs), with 16 Eph receptors (encoded by Eph genes) and 9 ephrin ligands (encoded by Efn genes) (Table 1) [2, [4] [5] [6] . Both Eph receptors and ligands are divided into either A-class or B-class, depending on the manner in which they are anchored to the plasma membrane. Eph receptors and their ephrin ligands are membrane-associated; thus, signaling is initiated exclusively from points of cell-tocell contact upon binding of the ephrin ligand of one cell to the Eph receptor of an adjacent cell. Ephrin signaling is bidirectional, with signals propagating into both the receptorbearing cells (forward signaling) and ligand-bearing cells (reverse signaling) [2] . Eph receptors and ephrins were initially implicated in cell positioning and migration during development, particularly of the nervous system; however, ephrins have since been shown to regulate cell positioning, migration, adhesion, and differentiation during the development of many other tissues, including the retina [7] , thyroid [8] , vasculature [9] , and mammary gland [10, 11] . Eph-ephrin signaling also regulates keratinocyte adhesion and differentiation [12] and hematopoietic stem cell adhesion [13] . Compelling evidence also suggests that Eph-ephrin signaling plays several important roles in cancer development and progression [3] . Expression of ephrin ligands and receptors is often reduced in advanced-stage tumors, and Eph-ephrin signaling regulates tumor growth, metastasis, and angiogenesis by altering cell proliferation, motility, invasion, and migration [3] . Given that FSH induces changes in GC morphology and adhesion during formation of a preovulatory follicle, we speculated that FSH may regulate Eph-ephrin gene expression, and that Eph-ephrin signaling may regulate GC function.
To date, a limited number of reports have described Ephephrin gene expression in the mammalian ovary [14] [15] [16] . Gale et al. [15] identified ephrin-B2 (EPHB2) in the endothelium of vessels surrounding and invading the theca interna of mouse preovulatory follicles and in the highly vascularized corpus luteum. Those authors suggested that EPHB2 regulates angiogenesis during the formation of preovulatory follicles and the corpus luteum. Egawa et al. [14] investigated the mRNA levels of all B-class ephrins in the human ovary during formation of the corpus luteum. They also demonstrated that EPHB1 localized to the theca interna and that EPHB2 bound to the surface of freshly isolated human GCs. Finally, Xu et al. [16] characterized the mRNA levels of ephrin A and B ligands and receptors in human GCs and detected expression of EPHA2, EPHA4, EPHA7, EFNA4, EFNB1, and EFNB2. This expression was unaffected by treatment of GCs with human chorionic gonadotropin (hCG) [16] . Finally, expression of EPHA4 has been detected in bovine theca cells [17] .
None of these studies investigated whether FSH regulates the expression of Eph-ephrin genes in the ovary, nor did they demonstrate a functional or behavioral effect of Eph-ephrin signaling on follicular cells, such as changes in cell shape and adhesion. Therefore, given that changes in cell shape and contact occur during GC differentiation both in vitro and in vivo in response to FSH signaling, and given that a subset of ephrins has been identified in GCs, we hypothesized that Ephephrin signaling may be a novel mechanism by which GC shape and adhesion are regulated and that expression of ephrin family members may be regulated by gonadotropins.
To determine if FSH regulates Eph-ephrin gene expression in mouse GCs, we examined the expression of the entire family of Eph-ephrin genes after FSH treatment of primary mouse GCs and an immortalized, FSH-responsive rat GC line (GFSHR-17) [18] . Using these models and recombinant ephrin ligands and receptors, we also investigated the functional effects of Eph-ephrin signaling on GC morphology and adhesion and identified beta-catenin as a potential downstream target of EFNA5 signaling in GCs.
MATERIALS AND METHODS

Cell Culture
The GFSHR-17 cell line is an immortalized, gonadotropin-responsive rat GC line [ 
Isolation of GCs
Ovaries were removed and immediately transferred to a 100-mm cellculture dish containing 15 ml of ice-cold M199 medium supplemented with 1 mg/ml of bovine serum albumin (BSA), 2.5 lg/ml of amphotericin B, and 50 lg/ml of gentamicin (all reagents from Invitrogen). Ovaries were pooled, and the GCs from each pool were then expressed by manual puncture with 25-gauge needles followed by pressure applied with a sterile spatula. Follicular debris was removed manually, and the GC suspension was filtered through a 150-lm Nitex nylon membrane (Sefar America, Inc.) mounted in a Swinnex filter (Millipore). The GCs were then pelleted by centrifugation at 250 3 g for 5 min at 48C followed by two washes in DMEM/F12 medium containing 1% penicillin/streptomycin solution (15070-063; Invitrogen). The final cell pellet was frozen at À808C for qRT-PCR studies or cultured in DMEM/F12 supplemented with 10% FBS for GC spreading and adhesion studies. For qRT-PCR studies, human recombinant FSH was obtained from Dr. A.F. Parlow (National Hormone and Peptide Program, National Institute of Diabetes and Digestive and Kidney Diseases). Forskolin was purchased from Sigma Chemical Co.
RNA Isolation and qRT-PCR
Frozen pellets of GCs were solubilized in TRIzol (Invitrogen), and RNA was isolated according to the manufacturer's protocol. RNA was further treated with DNase I, then reverse-transcribed using Superscript II (Invitrogen). Complementary DNA (cDNA) levels were detected using qRT-PCR with the ABI PRISM 7900 Sequence Detection System (Applied Biosystems) and SYBR Green I dye (Applied Biosystems). Primers were generated using Primer Express Software (Version 2.0; Applied Biosystems) ( Table 2 and Supplemental Table S1 ; all Supplemental Data are available online at www. biolreprod.org). Fold-changes in gene expression were determined by quantitation of cDNA from target (treated) samples relative to a calibrator sample (vehicle). The gene for ribosomal protein L7 (Rpl7) was used as the endogenous control for normalization of initial RNA levels. Expression ratios were calculated according to the mathematical model described by Pfaffl [19] , where ratio ¼ (E target ) DCt(target) /(E control ) DCt(control) and E ¼ efficiency of the primer set, calculated from the slope of a standard curve of log(ng of cDNA) versus cycle threshold (Ct) for a sample that contains the target according to the formula E ¼ 10 À(1/slope) and DCt ¼ Ct(vehicle) À Ct(treated sample). Three independent experiments were carried out, and the results were averaged for statistical analysis by a one-way ANOVA followed by a Tukey multiple comparison post-hoc test (Fig. 1) or by a two-tailed unpaired Student t-test (Fig.  2) .
Immunofluorescence
Dissected ovaries were immediately embedded in Cryomatrix (Fisher Scientific, Inc.) and frozen using liquid nitrogen. Tissues were cut into sections (section thickness, 6 lm), mounted onto slides (Fisher), and stored at À208C until use. Sections were fixed with 4% formaldehyde for 10 min, rinsed three times with PBS, then permeabilized with 0.1% Triton X-100 for 15 min. Sections were again rinsed three times with PBS, blocked for 30 min with blocking solution (5% BSA in 0.1% Triton X-100), then rinsed three times with blocking solution. The tissue was then incubated for 1 h with primary antibody specific to each target-namely, rabbit anti-EFNA5 (1:50; sc-20722; Santa Cruz Biotechnology, Inc.), rabbit anti-EPHA5 (1:50; ab5397-100; Abcam), and rabbit anti-pan-cadherin (1:100; ab6529; Abcam). Sections were then rinsed three times in blocking solution and incubated in secondary antibody [63] with permission from Elsevier and updated as indicated (i, [5] ; ii, [6] ; iii, [6] ). Ligands are listed in approximate order of decreasing affinity for each receptor.
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(fluorescein isothiocyanate-conjugated goat anti-rabbit secondary antibody, 1:250; F9887; Sigma). The tissue was then rinsed twice in PBS followed by a 5 min incubation in 4 0 ,6-diamidino-2-phenylindole (1:1000; Sigma), and slides were mounted with VECTASHIELD (Vector Laboratories). Slides were stored at 48C and visualized the following day with an AX70 Provis upright microscope (Olympus). Images were captured using Image-Pro 6.2 software (Media Cybernetics).
Cell Spreading and Adhesion Assays
Cell spreading and adhesion assays were based on similar assays used by others [20] [21] [22] [23] to study the effects of Eph-ephrin interactions on cell rounding, spreading, and adhesion. In these assays, recombinant ephrin ligand or Eph receptor protein is spotted onto tissue-culture plastic, after which cells are seeded onto the plates and allowed to attach. Rounding or adhesion is then quantified within the spotted area. In the present experiments, both primary mouse GCs and GFSHR-17 cells were used.
In these assays, recombinant human EFNA5/human Fc (immunoglobulin [Ig] G) chimera (374-EA; R&D Systems), rat EPHA5/human Fc chimera (541-A5; R&D Systems), or human Fc (IgG; 009-000-008; Jackson ImmunoResearch) was used. (Eph-ephrin recombinant proteins are commercially available only as Fc-fusion proteins, which interact with the preclustering antibodies.) Each of these recombinant proteins was first preclustered before application to tissue-culture surfaces by combining Fc with F(ab 0 ) 2 fragment rabbit anti-human IgG antibody (Fcc fragment specific; 309-006-008; Jackson ImmunoResearch) at a 5:1 molar ratio followed by gentle agitation at room temperature for 2 h. Preclustering of recombinant Eph receptor and ephrin fusion proteins is necessary to activate either the ephrin ligands or the Eph receptors, because this mimics the membrane Eph receptor or ephrin ligand clustering that occurs in vivo upon activation [24] [25] [26] . Serial dilutions in PBS were then prepared as follows: EFNA5/Fc at 74, 37, 18.5, and 9.25 lg/ml for the cell rounding/spreading assay and EPHA5/Fc at 83, 42, 21, and 10 lg/ml for the cell adhesion assay. These concentrations were chosen based on those used by Yin et al. [23] in similar experiments and resulted in equimolar amounts of EFNA5 and EPHA5 in each dilution. Droplets (3.5 ll) of preclustered Fc or EFNA5/Fc or EPHA5/Fc were placed onto a 60-mm tissueculture dish (Sarstedt) and incubated at 378C for 1.5 h to allow the protein to adsorb to the tissue-culture surface. For both assays, serial dilutions of the Fc (IgG) fragment were also spotted to correspond to each concentration of EFNA5/Fc or EPHA5/Fc to control for differences in the number of micrograms of protein spotted at each concentration; however, only the highest Fc concentration is reported as the control in Figures 4-7 , because no differences in either cell shape (see Figs. 4 and 5) or cell adhesion (see Figs. 6 and 7) were observed between the different Fc (IgG) dilutions. Droplets were outlined using fine permanent marker on the underside of the dish to distinguish between treated and untreated areas, and the dish was rinsed twice with 4 ml of ice-cold PBS to remove nonadsorbed EFNA5/Fc or EPHA5/Fc. The dish was then seeded with 1.4 million cells in a 4-ml volume of DMEM/F12 containing 10% FBS. Cells were incubated at 378C with 5% CO 2 for 2 h to allow the cells to adhere and spread. (The minimum time required to observe maximal cell spreading [i.e., 2 h] had been previously determined experimentally). Cells were then rinsed twice with PBS to remove media and nonadhered cells and fixed in 4% paraformaldehyde in PBS for 10 min at room temperature.
Quantitation of the effects of recombinant EFNA5/Fc on cell spreading. One 1003 image (1020 3 768 lm) was taken from the center of each spotted region using an IX70 microscope attached to an DP71 camera (both from Olympus). All cells within one 1003 field were visually scored as being ''spread'' (characterized by the presence of lamellipodia) or ''round'' (characterized by round morphology and complete absence of lamellipodia). The fraction of spread cells was determined by dividing the number of spread cells in each image of the EFNA5/Fc surface by the number of spread cells in the image from the control Fc (IgG) surface. Three independent experiments were carried out, and the results (see Figs. 4 and 5) were analyzed for statistical significance by a one-way ANOVA followed by a Tukey multiple comparison post-hoc test. Quantitation was based, as described, on an image taken from the center of the spotted region (see Fig. 6A , asterisk).
Quantitation of the effects of recombinant EPHA5/Fc on cell adhesion. The total number of cells within one 1003 field image obtained from the EPHA5/Fc surface was divided by the number of cells on the control Fc (IgG) surface, resulting in a value of one for the Fc-coated plates and fractions of one for the EPHA5/Fc surfaces. Note that the exact images in Figure 6 were not used for quantitation; they are presented to show the dramatic difference in adhesion between EPHA5-coated and noncoated regions. Three independent experiments were carried out, and the results (see Figs. 6 and 7) were analyzed for statistical significance by a one-way ANOVA followed by a Tukey multiple comparison post-hoc test.
Human Phospho-Kinase Array
To screen for potential downstream targets of EFNA5-induced signaling in GCs, such as the phosphorylation of kinases and their protein substrates, we used the Human Phospho-Kinase Array Kit (ARY003B; R&D Systems), which simultaneously detects the relative site-specific phosphorylation of 46 phosphorylated proteins or their targets. GFSHR-17 cells were seeded onto tissue-culture surfaces coated with EFNA5/Fc or Fc alone, and lysates were harvested at 15 and 20 min after seeding. We chose 15-and 20-min time points based on a search of the literature, which indicated that many of the signaling elements captured by the array exhibit maximum phosphorylation within 15 min of stimulation. These lysates were applied to the Human Phospho-Kinase Arrays, which were then developed according to the manufacturer's instructions. Spot intensities were also quantified using ImageJ software (National Institutes of Health, http://rsb.info.nih.gov/ij/) according to the manufacturer's directions.
Immunoblot Analysis: Beta-Catenin
The EFNA5/Fc or Fc (IgG) were preclustered before application to tissueculture surfaces by combining with F(ab 0 ) 2 fragment rabbit anti-human IgG antibody (Fcc fragment specific) at a 5:1 molar ratio followed by gentle agitation at room temperature for 2 h. The preclustered recombinant protein was then used to coat 60-mm tissue-culture dishes and incubated at 378C for 1.5 h, then rinsed twice with 4 ml of ice-cold PBS. The dish was then seeded with 2.1 million GFSHR-17 cells in a 4-ml volume of DMEM/F12 containing 5% FBS. Cells were incubated at 378C with 5% CO 2 for 15 and 20 min. At each time point, lysates were generated by placing the dishes on ice, gently rinsing the cells twice with ice-cold PBS, and scraping the cells in 100 ll of ice-cold RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS) supplemented with a protease inhibitor cocktail (1:100; P8340; Sigma) and a phosphatase inhibitor cocktail (1:100; P2850; Sigma). Lysates were then transferred to a 1.5-ml microcentrifuge tube, incubated on ice for 20 min with mild agitation, and then centrifuged at 15 000 3 g for 20 min at 48C. The supernatant was boiled in Laemmli buffer for 5 min and then analyzed using SDS-PAGE. The separated proteins were transferred to a polyvinylidene fluoride membrane at 100 V 
EPHRIN SIGNALING REGULATES GRANULOSA CELL BEHAVIOR (constant voltage) for 2 h at 48C. After blocking for 1 h in Tris-buffered saline and Tween 20 (TBST)/5% nonfat milk, the membrane was probed with rabbit IgG specific to beta-catenin (1:1000 in TBST/5% nonfat milk; D10A8; Cell Signaling). The membrane was then probed with horseradish peroxidaseconjugated donkey IgG against rabbit IgG (1:10 000 in TBST/5% nonfat milk) and visualized using ECL Plus (Amersham Biosciences) and Hyperfilm (Amersham). To assess equal protein loading, the membrane was subsequently probed using a rabbit monoclonal IgG against histone deacetylase 4 (HDAC4, sc-11418; Santa Cruz Biotechnology, Inc.). Densitometric analysis of immunoblot data (ImageLab 4.1; Bio-Rad) was then carried out to quantitate the ratio of beta-catenin:HDAC4.
RESULTS
Identification of FSH-Regulated Ephrin Ligands and Eph Receptors in Mouse GCs
To determine if FSH regulates Eph-ephrin expression in GCs of immature PND 23-28 female mice, we initially screened the mRNA levels of all known mouse ephrin (Efn) and Eph receptor (Eph) genes in GCs isolated from immature female mice treated for 48 h with either saline or 5.0 IU of eCG (Supplemental Figs. S1 and S2). Eph-ephrin gene expression was determined by qRT-PCR. Based on this screening, we chose a subset of Efn and Eph genes that appeared to be regulated by eCG to further verify and to investigate the possibility of a dose-dependent response to eCG. To do this, we purified mRNA from GCs isolated from immature female mice treated for 48 h with either saline, 3.25 IU of eCG, or 5.0 IU of eCG. Eph-ephrin gene expression was again determined by qRT-PCR. We verified that the mRNA levels of one Efn gene and three Eph genes were significantly increased by eCG (Fig. 1) . At 3.25 IU of eCG, significant increases in the ephrin ligand Efna5 and the Eph receptors Epha5 and Epha3 (Fig. 1,  A , B, and D) were observed. At 5.0 IU of eCG, significant increases in Efna5, Epha5, Ephb2, and Epha3 (Fig. 1, A-D) were observed, along with an apparent increase in Epha8, though the effect was not significant (P ¼ 0.08 by Student ttest). To demonstrate that these eCG-dependent increases in Efna5, Epha5, Ephb2, and Epha3 were specific to this subset of Eph-ephrin family members-that is, that eCG did not affect the expression of all Eph-ephrin family members-we also FIG. 1. Expression of a subset of ephrin ligands and Eph receptors is stimulated by FSH in mouse GCs. Wild-type PND 23-28 C57Bl/6 mice were treated with saline or eCG (3.25 or 5.0 IU/mouse) for 48 h. GCs were isolated by ovarian puncture and pooled, and then mRNA was isolated. The mRNA levels of Efna5 (A), Epha5 (B), Ephb2 (C), Epha3 (D), and Epha8 (E) as determined by qRT-PCR were compared to an Rpl7 control. Efna1 and Epha2 were similarly analyzed (F) to indicate that not all Ephephrin ligand and receptor mRNA levels are increased by eCG. Data represent the gene expression compared with the Rpl7 control and are presented as the average 6 SEM of three independent experiments. Differences in average mRNA levels between vehicle treatment and 3.25 or 5.0 IU of eCG were analyzed by a one-way ANOVA followed by a Tukey multiple comparison post-hoc test (Tukey test). A) Efna5. A statistically significant difference was found between the three treatments 3 as determined by one-way ANOVA (F 2,6 ¼ 18, P ¼ 0.003). Tukey test revealed that statistically significant differences between vehicle and 3.25 IU of eCG (a: P , 0.05), between vehicle and 5.0 IU of eCG (a: P , 0.05), and between 3.25 and 5.0 IU of eCG (a: P , 0.05). B) Epha5. A statistically significant difference was found between the three treatments as determined by one-way ANOVA (F 2,6 ¼ 14, P ¼ 0.006). Tukey test revealed statistically significant differences between vehicle and 3.25 IU of eCG (a: P , 0.05), between vehicle and 5.0 IU of eCG (a: P , 0.05), but not between 3.25 and 5.0 IU of eCG. C) Ephb2. No statistically significant difference was found between the three treatments as determined by one-way ANOVA, but comparison of means between vehicle and 3.25 or 5.0 IU of eCG by a two-tailed unpaired Student t-test revealed a statistically significant difference between vehicle and 5.0 IU of eCG (b: P , 0.02). D) Epha3. A statistically significant difference was found between the three treatments as determined by one-way ANOVA (F 2,6 ¼ 14, P ¼ 0.005). Tukey test revealed statistically significant differences between vehicle and 3.25 IU of eCG (P , 0.05), between vehicle and 5.0 IU of eCG (P , 0.05), but not between 3.25 and 5.0 IU of eCG. E) Epha8. No statistically significant difference was found between the three treatments as determined by one-way ANOVA. F) Efna1 and Epha2. Not all Eph-ephrin ligand and receptor mRNA levels are increased by eCG. Data represent the gene expression compared with the Rpl7 control and are presented as the average 6 SEM of three independent experiments. Differences in average mRNA levels between vehicle treatment and 5.0 IU of eCG were analyzed by a two-tailed unpaired Student t-test (d: P , 0.01). (Fig. 1F) in response to eCG. Efna1 mRNA levels did not increase in response to 5.0 IU of eCG; in fact, a significant decrease was observed (P , 0.01). In addition, expression of Epha2 was not significantly changed in response to eCG treatment (Fig. 1F) . These results indicate that FSH increases the expression of a subset of ephrin ligands and Eph receptors in GCs of immature mice. (Fig. 2) . Of the five Eph-ephrin family members increased by eCG in primary GCs (Fig. 1) , we found that expression of two of these genes, Efna5 and Epha5, increased in response to FSH in GFSHR-17 cells (Fig. 2, A and B) . Indeed, Efna5 mRNA levels were increased after 24 and 48 h of FSH treatment ( Fig. 2A) , whereas Epha5 mRNA levels (Fig. 2B ) increased only after 24 h of FSH treatment. Because FSH regulates many of its target genes in GCs via the cAMP-dependent protein kinase A (PKA) pathway [27] , we next wanted to determine if forskolin, a direct activator of adenylate cyclase, would increase Efna5 and Epha5 mRNA levels in GFSHR-17 cells. Again, Efna5 mRNA levels were increased after 24 and 48 h of forskolin treatment (Fig. 2C) , whereas Epha5 mRNA levels (Fig. 2D ) increased only after 24 h of forskolin treatment. We also investigated whether any of the other eCG-responsive Eph-ephrin family members identified in Figure 1 responded to forskolin in GFSHR-17 cells, but only Efna5 and Epha5 mRNA levels were affected. These results indicate that Efna5 and Epha5 are increased by FSH in both mouse and rat GCs and that this increase is mediated, at least in part, through a cAMPdependent pathway. Because Efna5 and Epha5 were the two Eph-ephrin family members from our screen that were both expressed in both mouse and rat GCs and were regulated by FSH and cAMP in both model systems, we chose to further investigate the localization and function of these genes during the rest of the present study.
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FSH and cAMP Regulate
Efna5 and Epha5 Expression in a Rat GC Line To determine if FSH increased the expression of Efna5, Epha5, Epha3, Ephb2, Epha3, and Epha8 in a species other than mouse, we treated GFSHR-17 cells (an immortalized, FSH-responsive cell line derived from primary rat GCs [18]) with human recombinant FSH (50 ng/ml) for 24 or 48 h and determined mRNA levels by qRT-PCR
Localization of EFNA5 and EPHA5 in the Mouse Ovary
Quantitative RT-PCR experiments indicated that Efna5 and EphA5 mRNA is present within mouse primary GCs. Therefore, we wanted to investigate EFNA5 and EPHA5 protein localization within the whole mouse ovary using immunofluorescence (Fig. 3) . To investigate EFNA5 and EPHA5 localization in follicles of various sizes and in the corpus luteum, immature mice were exposed to one of the following three treatments: saline for 48 h, 5.0 IU of eCG for 48 h, or 5.0 IU of eCG for 48 h followed by 5.0 IU of hCG for 24 h. EFNA5 (Fig. 3, A, C, E, G, and I) localized to the periphery (Fig. 3, G and I ) of GCs in a punctate pattern (Fig. 3I ) in follicles ranging in size from primary to preovulatory. Small preantral follicles generally expressed less EFNA5 (Fig. 3A,  arrowhead) than larger preantral or antral follicles. In both preantral and antral follicles, we frequently observed that EFNA5 immunoreactivity was higher in mural GCs than in cumulus cells (Fig. 3, A and G) , and this difference often appeared as a gradient, with EFNA5 density being highest near the basement membrane and lowest near the antrum (Fig. 3G,  arrow) . Interestingly, EFNA5 immunoreactivity was lower in corpora lutea (Fig. 3E ) than in preantral and antral follicles. Weak EFNA5 staining was also observed in the theca and interstitial cells (Fig. 3C) .
Localization of EPHA5 was similar to that of EFNA5, with immunoreactivity localized to the periphery of GCs in follicles ranging in size from primary to preovulatory (Fig. 3, B, D, F , H, and I), again with weaker staining in smaller follicles (Fig.  3B, arrowhead) . However, staining appeared to be uniform around the GC periphery, without the punctate appearance that characterized EFNA5 (compare Fig. 3, I vs. J). Finally, EPHA5 immunoreactivity appeared to be weaker in corpora lutea than in preantral or antral follicles (Fig. 3F) . Weak EPHA5 staining was also observed in the theca and interstitial cells (Fig. 3D) .
To verify that EFNA5 and EPHA5 localized to the GC membrane, we stained ovarian sections with a pan-cadherin antibody (Fig. 3, K and L) to detect the transmembrane cadherin proteins that form adherens junctions between GCs. We observed similar localization of both EFNA5 and EPHA5
FIG. 2. FSH and forskolin increase
Efna5 and Epha5 mRNA levels in the immortalized rat GC line GFSHR-17 [18] . GFSHR-17 cells were treated for 24 and 48 h with recombinant FSH (50 ng/ml; A and B) or forskolin (fsk; 10 lM; C and D), and mRNA levels of Efna5 and Epha5 were determined by qRT-PCR and compared to an Rpl7 control. Data are presented as the average 6 SEM of three independent experiments. Differences in average mRNA levels between vehicle treatment (veh) and fsk or FSH were analyzed by a two-tailed unpaired Student t-test (a: P , 0.01; b: P , 0.05).
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and pan-cadherin (compare Fig. 3, A and B vs. K, and Fig. 3, G and H vs. L), suggesting that both EFNA5 and EPHA5 are membrane-localized in GCs.
Note that for each primary antibody, no signal was observed in sections stained with secondary antibody alone, indicating the signal we observed was not due to nonspecific binding of the secondary antibody (data not shown).
Inhibition of GC Spreading by EFNA5/Fc
Although ephrins have been previously identified in the ovary, no functional role for ephrins in GCs has been shown. Therefore, we investigated what roles Eph-ephrin signaling may play in GC morphology or function. Because Eph-ephrin signaling inhibits spreading and causes cell rounding in vitro in other cell types [20, 28] , and because FSH induces GC rounding in both cultured primary cells [1] and GFSHR-17 cells [18] , we investigated the effect of EFNA5 on GC morphology using both GFSHR-17 and primary mouse GCs. To do this, we used a cell spreading assay used previously by others [20] [21] [22] [23] to study the effects of Eph-ephrin interactions on cell rounding, spreading, and adhesion in other cell types. Specifically, we seeded GFSHR-17 cells onto tissue-culture surfaces spotted with serial dilutions of a recombinant human EFNA5/Fc chimera (74, 37, 18.5, and 9.25 lg/ml) or onto surfaces spotted with Fc alone as a negative control (Fig. 4, A  and B) . GFSHR-17 cells plated onto the EFNA5/Fc surface were notably rounder and less spread (having fewer lamellipodia) than those on the Fc-coated surface (Fig. 4, A and B) . To quantitate the extent of cell spreading, we visually scored each cell as exhibiting either a rounded or a spread morphology (see Materials and Methods for details). We then calculated the ratio of rounded (nonspread) cells to the total number of cells scored (Fig. 4A, bar graph) . Spreading was significantly inhibited on EFNA5/Fc-coated surfaces but not on Fc-coated surfaces. The number of rounded cells increased approximately 3-fold on the 74 and 37 lg/ml of EFNA5/Fc-coated surfaces compared to Fc alone (Fig. 4A, bar graph) . To determine if this EFNA5-induced cell rounding could be observed in primary GCs, we conducted an identical experiment with primary GCs isolated from untreated immature mice. Again, EFNA5/Fc significantly inhibited cell spreading and increased cell rounding, although to a lesser extent than GFSHR-17 cells (Fig. 5A , bar graph; compare to Fig. 5A to Fig. 4A ). At an EFNA5/Fc concentration of 74 lg/ml, the number of rounded primary GCs was approximately 2-fold higher than when   FIG. 3 . Localization of EFNA5 and EPHA5 in the mouse ovary. Immature mice were treated either with saline for 48 h (A and B), eCG for 48 h (C, D, G, and H), or eCG for 48 h followed by hCG for 24 h (E and F). Ovaries were isolated and frozen, and EFNA5 and EPHA5 localization was determined by immunofluorescence with anti-EFNA5 and anti-EPHA5 antibodies. A pan-cadherin antibody was also used to detect membrane localization within the ovary (I and J). EFNA5 was found in the periphery of GCs of small primary to large antral follicles (A, C, E, G, and I) and 3 often took on a punctate appearance (arrowhead in I). Expression was lower in small preantral follicles (arrowhead in A) than in larger preantral or antral follicles. EFNA5 expression was reduced in corpora lutea (E). We observed similar localization of both EFNA5 (A and C) and pan-cadherin (K and L). Weak EFNA5 staining was also observed in the theca and interstitial cells (see, e.g., A and C). No EFNA5 signal was observed in sections stained with secondary antibody alone, indicating the EFNA5 signal observed was not due to nonspecific binding of the secondary antibody (data not shown). EPHA5 was localized to the periphery of GCs in follicles from primary to preovulatory (B, D, F, H, and J), with weaker staining in small follicles (arrowhead in B). EPHA5 expression was weaker in corpora lutea than in larger preantral or preovulatory follicles (F). Weak EPHA5 staining was also observed in the theca and interstitial cells. EFNA5 and EPHA5 immunoreactivity was stronger in mural GCs than in cumulus cells of antral follicles (arrowhead in D and G). We observed similar localization of both EPHA5 (B and H) and pan-cadherin (K and L). No EPHA5 signal was observed in sections stained with secondary antibody alone, indicating the EPHA5 signal observed was not due to nonspecific binding of the secondary antibody (data not shown). Original magnification 3100 (A and B), 3200 (C-H and L), and 3400 (I and J).
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FIG. 5. EFNA5 inhibits spreading and increases rounding of primary mouse GCs. GCs isolated from the ovaries of immature mice were seeded onto tissue-culture plates that had been previously spotted with serial dilutions of a recombinant human EFNA5/Fc chimera or the Fc fragment alone (top left) as a negative control. Primary mouse GCs displayed significantly less spreading and a more rounded morphology when plated onto EFNA5/Fc-coated surfaces compared to Fc-coated surfaces, as determined by the absence of lamellipodia (A: 9.25-74 lg/ml; B: 74 lg/ ml only). The fraction of rounded cells was quantified by dividing the number of rounded cells by the total number of cells in counted in the field of vision at 3100 (see Materials and Methods for further quantification details). Three independent experiments were conducted, and the difference in the ratio of rounded cells to total cells between Fcalone and each concentration of EFNA5/Fc was plotted (A; bar graph shows average 6 SEM). Differences in the average ratio of rounded cells to total cells were analyzed for all conditions by a one-way ANOVA followed by a Tukey test. A statistically significant difference was found between the five conditions as determined by one-way ANOVA (F 4,10 ¼ 6, P ¼ 0.01). Tukey test revealed several statistically significant (P , 0.05) differences between many of the conditions. The following comparisons were statistically significant (P , 0.05) but are not shown on the bar graph for clarity: Fc versus 74 lg/ml, 74 lg/ml versus 18.5 lg/ml, and 74 lg/ml versus 9.25 lg/ml. Original magnification 3100 (A) and 340 (B). [18] were seeded onto tissue-culture plates that had been previously spotted with serial dilutions of a recombinant human EFNA5/Fc chimera or the Fc fragment alone (top left) as a negative control. GFSHR-17 cells displayed significantly less spreading and a more rounded morphology when plated onto EFNA5/Fc-coated surfaces compared to Fc-coated surfaces, as determined by the absence of lamellipodia (A: 9.25-74 lg/ml; B: 74 lg/ml only). The fraction of rounded cells was quantified by dividing the number of rounded cells by the total number of cells in the field of vision at 3100 (see Materials and Methods for further quantification details). Three independent experiments were conducted, and the difference in the ratio of rounded cells to total cells between Fc-alone and each concentration of EFNA5/Fc was plotted (A; bar graph shows average 6 SEM). Differences in the average ratio of rounded cells to total cells were analyzed for all conditions by a one-way ANOVA followed by a Tukey test. A statistically significant difference was found between the five conditions as determined by oneway ANOVA (F 4,5 ¼ 64, P ¼ 0.0002). Tukey test revealed numerous statistically significant (P , 0.05) differences between many of the conditions. The following comparisons were statistically significant (P , 0.05) but are not shown on the bar graph for clarity: Fc versus 74 lg/ml, Fc verus 37 lg/ml, Fc versus 18.5 lg/ml, 74 lg/ml versus 18.5 lg/ml, 74 lg/ ml versus 9.25 lg/ml, 37 lg/ml versus 18.5 lg/ml, and 37 lg/ml versus 9.25 lg/ml. Original magnification 3100 (A) and 340 (B).
FIG. 4. EFNA5 inhibits spreading and induces rounding of immortalized rat GCs. GFSHR-17 cells
EPHRIN SIGNALING REGULATES GRANULOSA CELL BEHAVIOR plated onto Fc alone (Fig. 5) . Thus, EFNA5 reduces cell spreading of both a rat GC line and primary mouse GCs.
Inhibition of GC-Substrate Adhesion by EPHA5
Given that GCs express both ephrin ligands and Eph receptors, and given that Eph-ephrin signaling regulates cellular adhesion [29] , we wanted to determine the effect of EPHA5 signaling on GFSHR-17 and primary mouse GC adhesion (Figs. 6 and 7) . The coating/spotting technique in this experiment was similar to that used for the EFNA5/Fc cell spreading experiments (Figs. 4 and 5) , with serial dilutions of EPHA5/Fc (83, 42, 21, and 10 lg/ml). GFSHR-17 cells were seeded onto tissue-culture surfaces spotted with dilutions of EPHA5/Fc or Fc alone. We noticed a dramatic and significant reduction in cells adhering to the EPHA5/Fccoated surface compared to those coated with Fc alone (Fig.  6A ) that occurred in an EPHA5/Fc dose-dependent manner (Fig. 6B) . We quantified the extent of this reduced adhesion by counting the number of cells in the center of the EPHA5/ Fc-coated surface (Fig. 6B ) and comparing this to the total number of adherent cells on the Fc-coated surface (EPHA5-Fc:Fc ratio). As the coating density of EPHA5/Fc was reduced, the number of cells adhering to the coated surface increased (Fig. 6B ). We were then curious to know if EPHA5 would also inhibit adhesion of primary mouse GCs. Using a similar procedure, primary mouse GCs were plated onto FIG. 7. EPHA5 inhibits substrate adhesion of mouse primary GCs. A) Primary GCs were plated onto tissue-culture plates previously spotted with serial dilutions of a recombinant rat EPHA5/human Fc chimera. Mouse primary GCs adhered less to EPHA5/Fc-coated surfaces than Fccoated surfaces. The total number of cells attached to the EPHA5/Fc surface was divided by the number of cells on the control Fc surface, resulting in a value of one for the Fc-coated plates and fractions of one for the EPHA5/Fc surfaces. B) Three independent experiments were carried out, with the results presented as the average 6 SEM for statistical analysis by a one-way ANOVA followed by a Tukey test. A statistically significant difference was found between the five conditions as determined by oneway ANOVA (F 4,10 ¼ 20, P , 0.0001). Tukey test revealed numerous statistically significant (P , 0.05) differences between many of the conditions. The following comparisons were statistically significant (P , 0.05) but are not shown on the bar graph for clarity: Fc versus 83 lg/ml, Fc versus 42 lg/ml, Fc versus 21 lg/ml, 83 lg/ml versus 21 lg/ml, 83 lg/ml versus 10 lg/ml, and 42 lg/ml versus 10 lg/ml.
FIG. 6. EPHA5 receptor inhibits adhesion of immortalized rat
GCs to cell culture surfaces. A) GFSHR-17 cells [18] were plated onto tissue-culture plates previously spotted with serial dilutions of a recombinant rat EPHA5/ human Fc chimera or the Fc fragment alone (top left) as a negative control. The spotted region is marked by an asterisk and outlined by a dotted line; the uncoated region outside the spotted area is marked by a circle. B) The total number of cells within a single 3100 field image obtained from the EPHA5/Fc surface was divided by the number of cells on the control Fc (IgG) surface, resulting in a value of one for the Fccoated plates, and fractions of one for the EPHA5/Fc surfaces. Three independent experiments were carried out, with the results presented as the average 6 SEM for statistical analysis by a one-way ANOVA followed by a Tukey test. A statistically significant difference was found between the five conditions as determined by one-way ANOVA (F 4,10 ¼ 13, P ¼ 0.0005). Tukey test revealed numerous statistically significant (P , 0.05) differences between many of the conditions. The following comparisons were statistically significant (P , 0.05) but are not shown on the bar graph for clarity: Fc versus 83 lg/ml, Fc versus 42 lg/ml, 83 lg/ml versus 10 lg/ ml, and 42 lg/ml versus 10 lg/ml.
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EPHA5/Fc-coated surfaces, and the number of adherent cells was again counted (Fig. 7) . As observed for the GFSHR-17 cell line, cell adhesion was significantly reduced by approximately 70% at the highest concentration of EPHA5/ Fc (83 lg/ml), resulting in an inverse relationship between cell adhesion and EPHA5/Fc concentration (Fig. 7B) . These results suggest that EPHA5, acting through ephrin ligands present on GC membranes, can alter the adhesive properties of both mouse and rat GCs.
Beta-Catenin Is a Downstream Target of EFNA5-Induced Signaling in GCs
To screen for potential intracellular targets of EFNA5-induced forward signaling in GCs, we used the Human Phospho-Kinase Array Kit, which simultaneously detects the relative site-specific phosphorylation of 46 phosphorylated proteins and/or their targets. GFSHR-17 cells were seeded onto tissue-culture surfaces coated with EFNA5/Fc (37 lg/ml) or Fc alone, and lysates were harvested at 15 and 20 min after seeding. These lysates were applied to the arrays, and the blots were processed and the spot intensities quantified according to the manufacturer's directions. Only two proteins, beta-catenin and phospho-STAT5, were observed at both 15-and 20-min time points at different levels when comparing the blots for Fc (IgG) alone versus EFNA5/Fc. Beta-catenin protein levels were reduced to 0.16 and 0.51 of control values at 15 and 20 min, respectively. Similarly, phospho-STAT5 protein levels were reduced to 0.30 and 0.58 of control values at 15 and 20 min, respectively.
We decided to focus on the observation of reduced betacatenin levels after exposure to EFNA5 based on betacatenin's known association with adherens junctions and the actin cytoskeleton [30] , which would be relevant to the changes in cell morphology that we observe when GFSHR-17 cells are exposed to EFNA5. Therefore, we verified the reduced beta-catenin levels observed in the array by immunoblot analysis to detect beta-catenin under the same culture conditions used in the array. This analysis revealed that GFSHR-17 cells seeded onto EFNA5/Fc contained lower beta-catenin protein levels at 20 min after seeding (Fig. 8 ) than cells seeded onto Fc alone, confirming the reduction observed using the Human Phospho-Kinase Array. No differences were observed between EFNA5/Fc and Fc at 15 min after seeding. These results suggest that beta-catenin may be a downstream target of EFNA5 signaling.
DISCUSSION
In the present study, we have shown that FSH increases the expression of a subset of ephrin ligands and Eph receptors in primary mouse and immortalized rat (GFSHR-17) GCs and that exposure of GCs to EFNA5 and EPHA5 alters GC morphology and adhesion, respectively. These results suggest that Eph-ephrin signaling may play a role in the changes in GC contact and organization that occur within the follicle during folliculogenesis.
Eph-Ephrin Gene Expression Is Regulated by FSH via the cAMP/PKA Pathway in GCs
We have observed that eCG increases the expression of Efna5 and several of its receptors (Ephb2, Epha3, and Epha8) in mouse GCs. Interestingly, all Eph receptors that we observed to be increased in response to eCG bind preferentially to EFNA5 [4] (Table 1 and Fig. 1) , the sole ligand increased in response to FSH in our mouse GC model. This coordinate increase of an ephrin and several of its cognate receptors suggests an attractive model in which the expression of an ephrin ligand and its receptors are coordinately increased during the response to FSH, resulting in increased Eph-ephrin signaling that contributes to the formation of the developing follicle. Coordinated increases in Eph receptors and ephrin ligands have been previously observed in mouse skin cells under conditions of hypoxia [31] . In theory, this coordinated regulation by FSH would increase Eph-ephrin signaling when cell movement occurs, such as during antrum formation.
We found that treating rat GCs with FSH and forskolin resulted in increased expression of Efna5 and Epha5, suggesting that these genes are activated via the cAMP/PKA pathway [27] , as are many FSH target genes. Why only Efna5 and Epha5, but not Ephb2, Epha3, and Epha8, expression increased in response to FSH in GFSHR-17 cells is likely due to differences in species (mouse vs. rat) and in primary GCs compared to an immortalized GC line. To date, little is known 
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about what signaling molecules regulate the expression of ephrin ligand and Eph receptor genes, and to our knowledge, this is the first demonstration that cAMP regulates Eph-ephrin family members in GCs. Our data indicate that in GCs, cAMP increases Eph and Efn expression, suggesting that cAMP may similarly regulate Eph and Efn expression in other model systems.
EFNA5 and EPHA5 Localization During Folliculogenesis
In general, both EFNA5 and EPHA5 were more highly expressed in larger follicles, such as preantral follicles with many layers of GCs or antral follicles, than in smaller ones, such as primary follicles with one or two layers of GCs (Fig.  3) . This suggests that expression of EFNA5 and EPHA5 may be driven, at least in part, by FSH. Although primordial and primary follicle development is commonly accepted to be independent of FSH, recent evidence indicates that in immature mice (the model in the present study), primordial follicles respond to FSH [32] , suggesting that FSH may regulate GC differentiation and development in small preantral follicles as well, because the FSH receptor is expressed in mouse primary follicles [33] . Thus, FSH may be one factor increasing the expression of EFNA5 and EPHA5 in both small preantral and larger antral follicles, which would be consistent with our data that Efna5 and EphA5 mRNA levels increase in GCs of mice treated with eCG ( Fig. 1 ) and in GFSHR-17 cells treated with FSH. In addition, the punctate pattern of staining that we observe for EFNA5 (Fig. 3 , G and I) has also been observed for other ephrins, notably EFNA3 in glial cells of the hippocampus [34] .
An interesting observation was that EFNA5 and EPHA5 immunoreactivity was stronger in mural GCs than in cumulus cells of antral follicles (Fig. 3G) , with a gradient of staining between the two. A similar graded pattern of expression has been reported for mRNA of the luteinizing hormone receptor (Lhcgr); cytochrome P450, family 11, subfamily A, polypeptide 1 (Cyp11a1); and Cd34 mRNA and is hypothesized to result from an oocyte-stimulated MAD homolog 2/3 (Smad2/3) signaling gradient that is strongest in cumulus GCs [35] . A mural-to-antral gradient of expression has also been reported for connective tissue growth factor (Ctgf) mRNA in rat follicles [36] . Therefore, we hypothesize that EFNA5 and EPHA5 expression may also be regulated by an oocyte-derived factor, such as bone morphogenetic protein 15 (BMP15) or growth differentiation factor 9 (GDF9) [35] . Although very little is known about what factors regulate EFNA5 or EPHA5 expression, evidence indicates that EFNA5 expression is regulated by anti-Müllerian hormone (AMH) and glial cellderived neurotrophic factor (GDNF) [37] , both of which affect the transition from primordial to primary follicles.
Based on our immunofluorescence data, we cannot identify whether individual mouse GCs express EFNA5 alone, EPHA5 alone, or EFNA5 and EPHA5 simultaneously. Whereas activation of an Eph receptor on one cell by an ephrin ligand on a nearby cell is the most commonly reported interaction, overlapping coexpression of cognate Eph receptor-ligand pairs within the same cell has been frequently observed. For example, EFNA5 and EPHA5 are coexpressed in pancreatic beta-cells [38] , and EFNA5 and EFNA4 are coexpressed in motor neurons of embryonic chick spinal cord [39] . Therefore, it is possible that GCs express both EFNA5 and EPHA5 and, therefore, that neighboring GCs could activate each other through forward signaling, reverse signaling, or both.
EFNA5 Inhibits Spreading and Increases Rounding of GCs
Our observation that exposure of primary GCs and rat GFSHR-17 cells to EFNA5 induces cell rounding is consistent with the ability of EFNA5 to induce cell rounding in a number of other model systems. This cell rounding, often referred to as reduced cell spreading, has been associated with both increased and decreased cell migration, depending on the cell type. For example, spreading of rat primary vascular smooth muscle cells is inhibited on tissue-culture surfaces coated with EFNA1, resulting in a rounded cell morphology [20] . Similarly, addition of EFNA5 to cell-culture medium induces rounding of both immortalized human melanoma cells and EPHA3-expressing 293T cells [28] , which correlates with reduced adhesion. Those authors suggest this reduced adhesion would lead to increased cell motility. Similarly, Foo et al. [40] show that smooth muscle cells lacking EPHB2 are defective in spreading and show increased motility [40] . On the other hand, many reports suggest that reduced spreading (cell rounding) leads to reduced migration, such as the EPHA1-induced rounding and reduced migration observed in Human Embryonic Kidney 293 (HEK293) cells stably transfected with EPHA1 [41] . Thus, in the ovary, changes in GC shape and spreading may regulate migration during folliculogenesis.
In addition to changes in cell shape, ''[e]xtensive and intricate changes in the physical arrangement of cells'' (p. 6 [42] ) occur within a developing follicle during folliculogenesis, and for these rearrangements to occur, GCs must migrate within the follicle. Several stages occur during folliculogenesis when GCs (both mural and cumulus) are thought to migrate within the follicle. GCs migrate to surround the oocyte during the formation of primordial follicles (to form multiple GC layers during proliferation and formation of preantral follicles) and also during the formation of the antrum, which requires a significant creation of space within the follicle. Both older and more recent studies of cultured follicles indicate that on a twodimensional surface in the absence of FSH, GCs disperse and migrate across tissue-culture plastic away from the oocyte but reorganize to form an antrum when exposed to FSH [43] . Three-dimensional culture in hydrogels minimizes the extent of GC migration, yet GC outgrowth still occurs, allowing antrum formation [43] . In either model, GC movement clearly is critical to the formation of the antrum. Treatment with hCG enhances cumulus cell migration as determined by in vitro migration assays [44] . Finally, during formation of the corpus luteum, luteinizing GCs migrate toward the center of the luteinizing follicle [45] and can be shown to migrate using in vitro migration assays [46] . Numerous studies have shown that Eph-ephrin signaling simultaneously induces cell rounding, reduces cell spreading, and enhances cell migration and motility of a number of diverse cell types [22, 28, 41, 47, 48] . Therefore, the GC rounding we observe in response to EPHA5 could potentially regulate GC migration in vivo.
EPHA5 Inhibits Adhesion of GCs
Granulosa cell movement and differentiation during folliculogenesis are thought to require changes in cell-cell adhesion and cellular junctions during this time [49] . Not surprisingly, the type of junctions connecting GCs within the follicle change in both number and type during follicle growth [50] . Four types of cell-cell junctions have been identified in the ovary of various species: adherens junctions, gap junctions, desmosomes, and tight junctions [50] [51] [52] , with adherens and gap junctions being the best characterized. In smaller follicles, gap junctions exist, but adherens junctions and desmosomes predominate [50, 53] . As the follicle grows under the influence BUENSUCESO AND DEROO of FSH and other factors, the number of gap junctions increases, whereas the number of desmosomes and adherens junctions decreases [50, 53] . Gap junction number and size increase dramatically to their maximum frequency in the preovulatory follicle [1] , concomitant with a decrease in adherens junctions, and it is believed that this change leads to reduced cell-cell adhesion, allowing the formation of the antrum [54] .
In the present study, we observe that primary GCs resist binding when reverse signaling (i.e., signaling into the cell containing the ephrin ligand) is activated through the Eph receptor coated onto tissue-culture surfaces. This suggests that reverse signaling through an EPHA5-compatible ephrin ligand on the GC surface results in reduced adhesion and repulsion. Several recent reports support a role for ephrin ligand-mediated reverse signaling in reducing cell adhesion. In mice lacking EFNA5, midline fusion occurs in the developing neural tube [55] , and those authors propose that this fusion results from loss of Eph-ephrin reverse signaling that would normally promote cell repulsion. In that same study, ''an inverse correlation'' (p. 203 [55] ) was observed ''between Efna5 gene dosage and [cell] adhesion'' (p. 203 [55] ), and cells from Efna5-null mice displayed decreased adhesion compared to wild-type cells. In another study, ephrin-A-expressing retinal neurons avoid EPHA7-Fc surfaces during axonal outgrowth, suggesting that reverse signaling via A-class ephrin ligands promotes repulsion and/or reduced adhesion [56] . We speculate that in vivo, this reverse signaling through EFNA5 on GCs could lead to reduced cell-cell contact during, for example, formation of the antrum, when reduced cell-cell adhesion is required for GC migration. This would be similar to the role that Eph-ephrin signaling plays in the repulsive guidance of migrating neurons [29] .
Interestingly, Eph-ephrin signaling has been shown to crosstalk with adherens junctions, tight junctions, and gap junctions in other model systems [2] . In various tissues, gap junctions are critical for Eph-ephrin function in processes as diverse as cell sorting, insulin secretion, and osteogenic differentiation [38, 57, 58] . Thus, cross-talk between these junctions and Ephephrin signaling may also be occurring in GCs.
Although several published reports have described Eph receptor and ephrin expression in the mouse and human ovaries, none of these demonstrated an effect of ephrin signaling on GC characteristics or function. Gale et al. [15] found that EFNB2 is expressed in the neovasculature of corpora lutea and the theca cell layer of preluteinized follicles. Egawa et al. [14] showed that EFNB1 is expressed in luteal cells of the human corpus luteum. These reports suggest roles for ephrin ligands in the vascularization of the theca and corpora lutea as well as in luteal cells. Xu et al. [16] demonstrated that EPHA2, EPHA4, EPHA7, EFNA4, EFNB1, and EFNB2 mRNA are present in cultured human luteinized GCs. In line with the findings of Xu et al., we detected expression of several Eph receptors and ephrins in mouse GCs.
EFNA5 Reduces Beta-Catenin Protein Levels in GCs
We observed a reduction in beta-catenin protein levels in GFSHR-17 cells seeded onto EFNA5/Fc concomitant with rounding/reduced spreading. Beta-catenin has two primary functions in cells. First, in conjunction with alpha-catenin and E-cadherin, it forms a link between adherens junctions and the actin cytoskeleton. Second, it serves as a transcription factor in conjunction with proteins of the T-cell factor (TCF)/lymphoid enhancer-binding factor (LEF) family of transcription factors in the nucleus [59, 60] . In the cytoplasm, beta-catenin undergoes constant turnover, with phosphorylation, ubiquitination, and then proteasomal degradation [61] . We speculate that activation of Eph receptors cognate to EFNA5 in GFSHR-17 cells may regulate adherens junction assembly and/or degradation or lead to transcriptional effects through interactions of betacatenin with TCF/LEF family members. In the context of the growing follicle, beta-catenin degradation may affect remodeling of adherens junctions, leading to changes in the cytoskeleton, which occur during changes in cell shape [62] . In turn, changes in cell shape have been associated with changes in cell migration [28, 40, 41] . Reduced levels of betacatenin may also influence expression of TCF/LEF target genes in GCs that may influence cellular morphology. Further experiments will be required to fully delineate the relationship between EFNA5 and beta-catenin.
In summary, we have shown that EFNA5 and EPHA5 are expressed in mouse GCs, that forward signaling induced by EFNA5 regulates GC morphology by inhibiting cell spreading, and that reverse signaling induced by EPHA5 inhibits cell adhesion. The expression of EPHA5 and EPHA5 in follicles of various sizes suggests that they may play multiple roles during different stages of folliculogenesis. We speculate that further studies will indicate that these and other members of the Ephephrin signaling system play important roles in the development of healthy preovulatory follicles and corpora lutea throughout folliculogenesis.
